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A chemical study of a 'Terra 
Sigillata' medicinal tablet from a late 
17th century Italian medicine chest 
Andrew Hardy* and Gavyn Rollinson** 
*Centre for Medical History, College of 
Humanities, University of Exeter, Devon, UK 
**Camborne School of Mines, University of Exeter 
in Cornwall, Tremough Campus, Penryn, 
Cornwall, UK 
It is probable that Wendel Thumblardt was one of the first 
volunteers to be utilised in a drug trial. He was a 
condemned-to-hang robber, in Langenburg (Germany) of 
the late 16th century. After sentence was passed on him he 
made an unusual proposal to the authorities. That they 
would give him a lethal dose of poison, followed by a well 
known (but not reliably tested on a human being) poison 
antidote called Terra Sigillata (lit. 'sealed earth' - that is, 
some moist clay that had been stamped with an image of 
a seal). Ifhe survived he would go free, ifhe died then the 
poison antidote would have failed ( and he was going to 
die anyway). 1.2 The authorities agreed to his proposal. 
Thus on the 25th January 1581, in the presence of 
various nobles and notables, he was given ' ... a dram and 
a half of Mercurie Sublimate, mingled with conserve of 
Roses, and immediately after a dram of the Terra Sigillata 
in olde wine'. The amount of poison (mercuric chloride, 
HgCh) was more than enough to kill an average-sized 
man. Then, though the poison did ' ... extremely torment 
and vexe him; yet in the end the medicine overcame it' .1.2,3 
The authorities kept their side of the proposal and he was 
freed. 
Being poisoned was an occupational hazard for the elite 
of Europe for centuries. An antidote that worked was 
much sought after; thus an offer of a controlled trial on a 
human being using the well known Terra Sigillata poison 
antidote was an offer that was always going to be readily 
accepted. 
Unsurprisingly there were many different poison 
antidotes available in past centuries and whilst many were 
herbal (i.e. organic), some were earth-based (i.e. 
inorganic). 4 Some of the latter were based on clays or clay 
minerals.5 The layer-type structures of clay minerals, with 
their adjustable distances between layers that give variable 
amounts of space for small molecules (such as water) and 
ions, gives rise to their absorption and ion-exchange 
properties. These properties are in turn responsible for 
various internal medicinal uses (past and present), such as 
for treating diarrhoea, stomach-ache, acid indigestion, a 
dietary deficiency, and as a detoxifying agent (i.e. poison 
antidote). 1,4,6,7,8 
Thus, whilst medicinal clays have been recorded for 
almost five millennia (and probably known, but 
unrecorded, for much longer), the terra sigillata tablets ( or 
sometimes troches, pastilles, cakes, lozenges, coins, 
usually circular in shape and red/yellow/white in colour) 
have 'only' been recorded for about two millennia. Both 
Dioscorides ( c. 40-90 CE) and Pliny the Elder (23- 79 
CE) recorded the tablets' existence in the first century. 
Galen of Pergamon ( c. 130-210) gives a detailed account 
of his visit in 167 to a well known manufacturing site of 
the tablets on the Greek island of Lemnos (NE Aegean 
sea). The Lemnos tablets were possibly the first to be 
made and did become the most well known. However, by 
the 14th century the demand for them had far exceeded 
supply and so several European countries had taken to 
making their own tablets using cheaply available local 
clays. Each country adopted their own images for the seals 
used, although these images did sometimes change over 
time. So, by the early 17th century there were many 
versions of terra sigillata tablets available, some 
unfortunately being counterfeit. One of the best known of 
these alternative tablets were those from Silesia (then part 
of the Hapsburg Empire and now mostly in SW Poland) 
and were called Terra Silesiaca. Examples of other 
countries making their own tablets were: other Greek 
islands (e.g. Chios, Samas and Kimolos), Malta, Turkey 
(which includes their taking over the island ofLernnos in 
1456), Armenia, France, England, Germany and Italy.3.9, 10 
Further information on the composition and uses of some 
terra sigillata tablets (and their associated clays) will be 
given in the later Discussion section. 
We were recently fortunate to be allowed access to a 
well provenanced late 17th century Italian medicine chest 
with a view to removing small amounts of some of the 
medicines for chemical analysis. The chest was given, in 
December 1698, to John Clerk of Penicuik (1676-1755, 
and second baronet from 1722) just before his departure 
from the Florentine court of Cosimo ill (1642- 1723), 
Grand Duke of Tuscany (reigned from 1670). The chest 
was later described, by its new owner, as 'a Box of 
chymical medicines'. 11,12,13 Figure 1 shows the top tray of 
the opened chest, and Figure 2 shows two of the 
medicinal tablets under study. 
Analytical Methods and Results 
In the left comer of the top tray of the chest is a small 
gold-coloured container (see Fig. 1 and in the 
background of Fig. 2). The tablets inside this container 
Figure 1. The opened medicine chest. 
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Figure 2 The medicinal tablets and their two seals. 
are between 18 and 20 mm in diameter and 2 to 3 mm in 
thickness. We estimate that a whole tablet weighs approx. 
two grams (i.e. almost exactly half a dram). Already 
broken-off small fragments of these grey-white tablets 
were ground to give a light yellow-brown powder, which 
was then used in the subsequent chemical analyses. 
The analytical techniques used were: LVSEM (Low 
Vacuum Scanning Electron Microscopy), XRPD (X-Ray 
Powder Diffraction) and QEMSCAN (Quantitative 
Evaluation of Minerals using Scanning Electron 
Microscopy). The first technique gives a quantitative 
summary of the elements present ( down to and including 
an atomic number of 6, i.e. carbon); the second gives 
semi-quantitative data on the crystalline compounds 
present and the third technique gives quantitative data on 
the inorganic/mineral compounds present (regardless of 
if they are crystalline or amorphous ).14 
The analytical results for our sample ( designated 'P9') 
are given below in the following way: first the LVSEM 
results in decreasing order of elemental weight percent 
(with the elements in ordinary brackets being at less than 
1 % each, and the element in square brackets was only 
later found in a ' spot' scan, where a 'spot' scan is an 
analysis over a circular 'spot' of only 2 to 3 µm in 
diameter, compared to a normal ('area') scan done over a 
rectangle of between 200 to 400 µm a side), then the 
combined results ofQEMSCAN and XRPD. The former 
technique sometimes only identifies a group of inorganic 
compounds, whilst the latter technique can usuall_Y 
identify the actual inorganic compound present from this 
group. Thus we have given the QEMSCAN res~ts ~t 
and with the associated XRPD results given m 
subsequent brackets. 
LVSEM: 0, Si, Al, Fe, K, Mg (Ti, Na) [Sn] 
QEMSCAN (XRPD): Kaolinite 66.9% [ an aluminium 
silicate, AhSizOs(OH)4]; 
Muscovite or Illite 16.0% [Muscovite, 
K(Mg,Al)204(Sb ~o 66)01o(OH)2]; 
Chlorite (Group) 10.2% [most likely Clinochlore, 
(Mg,Fe)sAhSh 01o(OH)s]; 
Biotite 2.4% [K(Mg,Fe)i(AISh010XOH)z]; 
a K-feldspar 1.7% (Microcline, KAIShOs); 
Rutile 0.9% (Titanium oxide, Ti02); 
a plagioclase feldspar 0.9% (probably Albite, 
NaAIShOs); 
Quartz 0.5% (Silicon oxide, Si02); 
an Iron oxide/carbonate 0.4% [most likely Goethite, 
FeO(OH)]; 
with the remaining 0.1 % made up of: a Mg-silicate [ most 
likely Talc, Mg3S~010(0H)2], Cassiterite (a Tin oxide, 
Sn02), and several other compounds ( calcite and various 
silicates) each present in 'trace' amounts [i.e. at less than 
100 ppm (0.01 %)]. 
Discussion 
Only a few chemical analyses of actual terra sigillata 
tablets have been done. About a century ago a small 
sample of a 16th century terra sigillata tablet from 
Lenmos was analysed and the results given as: silicates 
37.23%; calcium oxide 12.90%; aluminium oxide 
13.51 %; ferric oxide 4.08%; magnesia and alkali oxides 
1.50%; water and carbon dioxide 17.72%; moisture 
3.06%. 10 These results were later interpreted to give the 
sample's approximate composition as: calcite 40%; 
quartz 24%; illite 20%; kaolinite 13%; water 3%.2 
In 1945 a paper was published on the analysis of a 
' grey-violet tablet' that was an example of Terra 
miraculosa Saxoniae (miracle earth from Saxony, 
Germany). However, it is unclear if the tablet was 
actually stamped with a seal. Its composition was given 
as: two-thirds kaolinite, with the remaining one-third 
consisting of quartz, (a) mica and lirnonite 
(FeO.OH.nH20). 2 
In 1960 a report was written on the chemical analysis 
of powders from seven troches of terra sigillata from the 
Hans Sloane Collection (all of which were originally in 
the British Museum, but these and other mineralogical 
sampies were later transferred to the National History 
Museum). One sample had illite, one montrnorillonite, 
one well crystallised kaolinite, two disordered kaolinite 
and one an unspecified type ofkaolinite as the dominant 
clay mineral present. The seventh sample was described 
as being identical to one of the above six samples, but 
exactly which sample is unknown.2 It is assumed that 
these seven troches were some of the fifteen troches of 
bright pinkish coloured terra sigillata tablets from 
Lenmos and dated to the 18th century that were found in 
one (of two) drawer(s) of mineral pharmaceutical 
specimens in the Sloane Collection (and now on display 
at the Natural History Museum). 15 
A 1973 paper gave chemical composition data on 21 
'disks' of terra sigillata from Lower Slesia/Silesia. They 
are described as being various colours: yellow, brown 
and one being black. Their composition was said to be 
based mainly on montrnorillonite and illite; with some 
containing bentonite ( altered volcanic ash, with its major 
component being montrnorillonite) and others 
kaolinite.16 No date of their manufacture was given. 
The most recent analysis was published in 1997 and 
was a chemical study of two terra sigillata tablets from 
the Greek island of Samos (about 300 km SSE of 
Lenmos). The samples were both from a private 
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collection and their dates had been estimated to be of the 
5th to 6th century BC, which, if confirmed, would make 
them the oldest known examples of such tablets. One 
sample was red and one white. Both were found to have 
had organic matter mixed with soil. The latter was 
consistent with soils from Samos, but for the white 
sample could also match some soils of the Anatolian 
peninsula (i.e. what is now approximately the western 
two-thirds ofTurkey). 
The authors of the paper used the analytical techniques 
of EDX (energy dispersive x-ray micro-analysis for 
elemental determination) and x-ray diffraction analysis. 
Using their results from the latter technique we have 
estimated the percentages of the compounds present in 
both samples. For the red sample (with our approximate 
percentages given in brackets): quartz (66), kaolinite (4), 
illite (3), illite-smectite (27); the sample's red colour was 
probably given by the presence of a small amount of 
hematite (Fe20 3). Similarly, for the white sample: quartz 
(42), gypsum (CaS04.2H20) (30), kaolinite (24) and 
illite (4). 17 
Additionally, clays have been analysed from modem-
day deposits in regions where the tablets were known to 
have been made in centuries past. However, past surface 
clay deposits will have disappeared or changed over such 
time scales from both usage and weathering. Even below 
the surface clay deposits of the past could have been 
chemically altered or have been significantly depleted by 
human activity over time. Samples from various modem-
day clay deposits on the island of Lemnos have been 
chemically studied. One such study found that their clay 
samples were 'rich in smectite and specifically in Ca-
montmorillonite' .18 A second later study found 
montmorillonite in both their red and white clay 
samples. 19 
An interesting hypothesis has been proposed as part of 
a determination of the composition of old terra sigillata 
tablets made from material at a particular deposit on 
Lemnos. Using several analyses of nearby rocks and a 
consideration of the local water (which flowed over this 
particular deposit for some time prior to clay samples 
being taken), plus by considering documentary evidence 
of tablet production and its properties, it was reasoned 
that the composition of old tablets made from material at 
this deposit would have been ( approximate percentages 
given in brackets): montmorillonite (40), a kaolin group 
clay mineral (35), alum (Alz(S04)3. l 7H20, possibly 
containing some potassium) (20) and hematite (5). The 
'interesting hypothesis' being that the flowing water, over 
time, added the alum to the clay deposit and where the 
authors identify it as a major active ingredient (acting as 
an astringent).9•10 
On comparing the composition of our tablet with the 
results from the above mentioned five publications it can 
be seen that none of their results are an exact match for 
ours. The first and fifth have percentage amounts given 
for the compounds present, but contain relatively large 
amounts of calcium compounds ( calcite and gypsum 
respectively) where our sample has calcite only in a 
'trace' amount. Whilst the second paper's sample does 
Figure 3. Terra Sigillata tablets from the collection 
of the Museo di Arte Sanitaria, Rome. 
have an exact match for the amount ofkaolinite present, 
its mica is not identified and its quartz percentage must 
be larger than in our sample. Some of the third and fourth 
papers' tablets do have as their major component 
kaolinite, but the remaining compounds in these samples 
are unknown. The studies done on Lemnos clay deposit 
samples all show montmorillonite (which is not found in 
our sample) as the dominant compound present. Finally, 
the reasoned study for the composition of old Lemnos 
terra sigillata tablets does give kaolin (where the most 
commonly found member of this group of clay minerals 
is kaolinite5) as being present in a significant amount, but 
it also lists montmorillonite and alum as being present , 
both of which are not found in our sample. 
At the time period of the existence of our medicine 
chest (late 17th century) many European countries had 
found local clay deposits with which to make their own 
( distinctively sealed) terra sigillata tablets. Thus we feel 
that a local (i.e Tuscan) clay source for our sample is 
probable. Tablets variously called Terrae Sigillatae 
Florentina (sealed earths of Florence), Terra Florentina 
( earth of Florence) and Terra Magni Ducis/Terra de/ 
Gran Duca ( earth of the Magnificent/Great Duke) are 
known to have existed and are all thought to be made 
from local clay, which was said to excavated at 'various 
sites in Tuscany' and also from a surface deposit 'around 
Florence' .10 Tablets said to be sealed with the arms of the 
Medici family are shown in Figure 3; they have been 
dated to the 17th century and are said to have been made 
of clay from the island ofElba.20 Other tablets with the 
Medici seal come from the nearby Giglio (Lily) island. 16 
Both of these islands are part ofTuscany. 
Using as input the three major minerals found in our 
sample (i.e. kaolinite, muscovite and a member of the 
Chlorite Group) to the search engine of a mineral 
website/database we found several Tuscan modem-day 
mines that are listed as having them present. Only one of 
these mines is known to have been used in the (late) 17th 
century (the Bottino mine in the Apuan Alps, Lucca 
Province of Tuscany, and approximately 100 km NW of 
Florence). Also the island ofElba was known to have had 
several excavated sites in this time period, and the one 
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(the Calamita mine) we identified as probably having all 
three minerals in the present day may have been so used 
in the past. 21 ' 
It is known that in the time ofCosimo I (1519- 1574) 
as (1st) Grand Duke of Tuscany there were experiments 
to make porcelain, using various sources of clay (both 
local and from further afield in Europe). These 
experiments probably started in 1565, in a specially built 
pottery in Florence. After ten years the Grand Duke ( now 
Francesco I, 1541- 1587) succeeded in making a proto-
porcelain, which eventually became known as Medici 
porcelain. Small scale production started in 1576 and 
continued until about 1610. The kilns for this production 
were situated at the Casino di San Marco (probably 
where the Museum of San Marco now stands, and which 
is about 1200 m north of the present-day Uffizi Gallery) 
and in the Boboli Gardens (which is behind the Pitti 
Palace; which in turn is about 650 m, over the Ponte 
Vecchio, from the U:ffizi gallery).22 It is possible that one 
of the clay sources tried for porcelain making and which 
failed at this enterprise was re-used by the Grand Duke 
as a medicinal clay in terra sigillata tablets. 
The coat of arms shown on the tablet at the bottom of 
Fig. 3 is said to be that of the Medici family. The crown 
above a shield containing six balls, and outside the shield 
'M' and 'R' on the left and 'D' and 'VI' on the right, are all 
the same as shown on our tablet (see right hand image of 
Fig. 2). These symbols may stand for 'Magni' 
(Magnificent), 'Duci' (Duke), 'Regno' (reign) and the 
'VI' possibly for the fact that Cosirno III was the sixth 
• 
• 'I 
Figure 4. 'Dosage leaflet from John Clerk of Penicuik's 
medicine chest. 
Grand Duke of Tuscany. Our tablets, like those in Fig. 3 
and others of at least the 17th and 18th centuries, had two 
seals stamped on each original piece of moist clay, front 
and back, before being left to harden. 
As to the other seal on our tablets (see left hand image 
ofFig. 2), it is sirpilar to the one seen at the top of Fig. 4. 
This latter image is taken to be the seal for the Grand 
Duke's fonderia (foundry). A translation of Fig. 4, a 
'dosage leaflet' for Terra Sigillata from an empty space 
in the bottom drawer of our medicine chest ( and where 
this leaflet does not have the usually found 'imprint' of a 
glass container on it and so it is assumed that our tablets 
were always in the gold-coloured container of the top 
drawer) is given below (and where the words in square 
brackets have been added by us): 
TERRA SIGILLATA 
Of the Fonderia [Foundry] ofS. A. S. 
It is of use for extinguishing the evil of fever. 
It is resistant to putrescence. 
It reduces dysentery and body fluids. 
It is of use against poisons. 
It stops spitting of blood and it is wonderful in 
illnesses involving worms. 
Its dosage is one of those round pastilles, taken 
in whichever way, either with water of 
Plantago major [ a herbal tea?], or wine, or 
other similar [liquids]. 
It can be added to mushed food, powdered 
and it can be taken in any [other] way; 
as this [clay] is processed differently from 
all the other 'terre sigillate' in the Foundry 
ofS.A.S., with a special secret [recipe?]. 
[[SAS. is SuaAltezza Serenissima(HisMostSereneHighness)] 
The fonderia of the Grand Dukes ofTuscany was their 
workshop/laboratory for research into and the production 
of various materials relating to the Arts and to Alchemy. 
In addition to the initial furnaces for smelting and forging 
metals, there were added over time facilities for studying 
and making: medicines, porcelain, cabinets, 
confectionery, clocks and other mechanical devices, and 
for the cutting of precious/semi-precious stones. Its 
location varied over time; it being found, in 
chronological (if sometimes overlapping) order, in the 
Palazzo Vecchio (located at the NE end of the Uffizi 
gallery), the Casino di San Marco and in what is now the 
Uffizi gallery itself However, from the time of the reign 
of Cosimo II (1590-1621; reigned from 1610) its 
prestige and facilities decreased and under his successor 
(Ferdinando II, 1610-70) its budget, and hence output, 
was increasingly reduced. Under Cosimo III the fonderia 
was moved to the Palazzo Pitti where it apparently 
functioned only as a pharmacy.23.24 The very existence of 
our chest and its contents confirms the above and also 
suggests an associated workshop for making the 
medicine chests and their distinctive 'dosage leaflets'. 
Sometimes, various 'additives' were added to the moist 
clay before they were stamped and left to harden. Perhaps 
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the most (in)famous of these is the goats blood, said by 
Dioscorides (in the first century CE) to have been added to 
the clay by a priestess on Lemnos. When Galen, about a 
hundred years later, mentioned it to the islanders it was 
greeted with laughter and regarded as 'a joke' .19 More 
reliably, it is known that the terra sigillata clay was later 
sometimes used as one ingredient of a medicinal recipe. 
One example is (where the extra information in brackets 
has been added by us): clay plus 'mineral unicorn' 
(possibly a whitish earth from Silesia3) , 'oriental bezoar 
stone' (an accretion found in the stomach of a Persian 
goat), 'alcohol from oriental mother-of-pearl ' (mother-of-
pearl is mostly aragonite, a form of calcium carbonate), 
'Diaphor of antimony' (this is said to be a mixture of 
antimonic acid and its potassium salt, and where a 
'Diaphoretic' drug is one that induces sweating), 
'confection of hyacinth berries' and 'gelatine of Italian 
vipers'. Such recipes were used, in the late medieval 
period at least, against snake and mad dog bites, the 
plague, fevers and 'pestilence' .16 There is no chemical 
evidence of any such additive(s) being added to our 
sample. 
The various medicinal uses of terra sigillata tablets 
and their associated clays have already been mentioned 
(see Introduction and above), and uses for our tablets are 
given in its ' dosage leaflet' (Fig. 4). Recent studies into 
the medicinal uses of clays have shown that various 
kaolins can be used effectively: as haemostatic wound 
dressings, to aid blood clotting (kaolinite); in (targeted) 
drug delivery, as a carrier (halloysite); and some 
( currently only found using a mixture of kaolins and 
other clays) are antibacterial. Toxicity from kaolins is 
rare if ingested, but fibrosis can occur from long-term 
exposure (inhalation).25 
Conclusions 
Our sample consists almost entirely of silicates. Its three 
major components are kaolinite (67%), muscovite (16%) 
and a member of the Chlorite Group of silicate minerals 
(probably clinochlore) (10%); and with the other 
compounds found shows that the original material was 
almost certainly a naturally occurring clay. As to exactly 
where this clay was found, there are several possibilities, 
with the most likely in our opinion being a local (Tuscan) 
source. Surface or deeper deposits near Florence are a 
possibility, but the deposits on the islands ofElba or The 
Lily seem to us to be the more likely. The Grand Dukes 
of Tuscany may have been 're-cycling' a clay from a 
failed porcelain-making experiment, from when the first 
such experiments were done (i.e. c. 1565- 1575). It is 
thought that the clay for our tablets would have arrived 
at the fonderia for stamping with seals only a short time 
before our medicine chest was given to John Clerk of 
Penicuik in late 1698. 
The chemical composition, size, shape, colour and 
identifiable seals of our tablets, plus the presence of a 
'dosage leaflet' and the excellent provenance of the 
medicine chest, shows us that they are genuine terra 
sigillata tablets. Thus, they would have been expected to 
work against ingested poisons by their new owner. As far 
as we are aware the new owner of the medicine chest, or . 
any of his descendants, never so used a tablet. However, 
given that one tablet is only about half a dram then taking 
one in 'olde wine' would probably not have been enough 
to have saved the life of one Wendel Thumblardt. 
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A study of an ointment from a late 
17th century Italian medicine chest 
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Being burnt or scalded must have been a very common 
occurrence before the advent of electrical lighting and 
closed oven cooking. The following burns treatments 
(with one important addition, which will be mentioned 
separately) have all been variously used over time: 
applying cooling lotions (these include the use of cold 
running water, which is still recommended, and the 
application of fresh human urine, which though 
efficacious, is not now totally culturally acceptable); 
application of heat to the burnt area (to remove moisture 
and aid fluid removal); covering the burn wound with 
material that was transparent, porous and which could be 
readily sterilised (e.g. cellophane); surgery, initially to 
remove loose skin/flesh and later for skin grafting/plastic 
surgery; and treating the patient for shock by keeping 
them warm and drinking fluids. i,2,3 The addition is of 
course the application to the affected area of the skin one 
of a vast array of unguents/ointments, salves and sticky 
balms. These are what we will mainly cover in this article. 
The earliest known written record of burn medicines is 
in the Ebers papyrus of ancient Egypt. It was written in 
c.1550 BC, but probably contains older remedies. The 
papyrus contains a section entitled 'Beginning of the 
remedies for a burn' . The remedies given include the use 
of (either individually or with other materials): honey; 
copper flakes; malachite (basic copper carbonate); fat; 
oil; animal excrement; black mud; and a variety of plants. 
The final remedy listed reads: 'Another: barley bread, 
oil/fat and salt, mixed into one. Bandage with it often to 
make him well immediately. A true thing. I have seen it 
happen for me. ' 4 
Herbal remedies were often used in the medieval 
period ofWestem Europe (i.e. c.500 to c.1500AD). Two 
such examples for burns are: a) 'take the plant [Greater 
Celandine (Chelidonium maius)] and pound it with 
goat's grease, and lay it on the burn'; and b) 'for a bad 
burn, take the roots of ancusa [alkanet] plant soaked in oil 
and then mixed with wax like you would to make a 
plaster or poultice. Apply this to the burns, and it will heal 
them in a wonderful manner ' [with words in square 
brackets added by the author ).5 
In the early modem period of Western Europe a 
famous treatise on the classification, prognosis and 
treatment of burns was published, written in 1607 by 
Wilhelm Fabry ( 1560 - 1634), using his latinised name of 
Guilhelmus Fabricus Hildanus, when he was a surgeon 
in the small town of Payeme (in what became the Vaud 
region of Switzerland). His recipes were simple, 
pragmatic ( case study details of their use were sometimes 
given) and free of the poly-pharmacy commonly used at 
the time. Two examples are: a) raw onions (1.5 oz), salt 
(1.0 oz), white and blue soap (Castilian soap) (1.0 oz), 
mixed in a mortar and made into an ointment using rose 
and sweet almond oils; and b) 'Basilicon Ointment' 
made from yellow wax, black pitch, resin (0.5 lb each) 
and olive oil as required. The first was for small burns 
and the second for later blisters; and where 12 ozs = 1 
pound, 1 oz= 8 drams/drachms = 31.1 g.6 
In the present day folk/alternative medicines are still 
used as skin balms for burns. In a recent study of zoo-
therapeutic remedies used in the Mediterranean (in the 
interior and . mountainous regions of Italy, Albania, 
Serbia, Croatia and Romania) it was found that honey 
and (separately) cow/dog faeces were applied to burns.7 
Both of these remedies were known to and used by the 
ancient Egyptians of over three millennia ago. 
In orthodox western medicine of the present day burn 
wound management includes oral or intravenous 
hydration, topical application of various antisepti 
antimicrobial/anti-inflammatory creams or ointments 
with appropriate dressings, and oral antibiotics and 
analgesic medicines. Worldwide each year over 300,000 
people die from severe burns. To preserve our largest 
organ, the skin, as much as possible should be done to 
protect and heal it from the 'slings and arrows' of 
misfortune. One such way is to use the best possible 
material(s) for topical application to the affected skin, 
and new research is being done on various natural bio-
resources for their antimicrobial, anti-inflammatory and 
stimulation of new cell growth abilities. Examples 
include honey, Aloe vera/Aloe barbadensis, and 
Hypericum perforatum (St John's wort), which have all 
been known for their wound-healing properties for many 
years. Extracts from various fungi may well also prove 
valuable in wound care. 8 
Only some of the very many skin balms used for burns 
over the last few millennia have been mentioned above, 
and further information on additional relevant historical 
recipes will be given in the later Discussion and 
Conclusions section. They are found in the literature and 
also where old residues, or their modem-day repro-
ductions, have had analytical chemistry techniques 
applied to them. 
I was recently fortunate to be allowed access to a well 
provenanced late 17th century Italian medicine chest 
with a view to removing small amounts of some of the 
medicines for chemical analysis. The chest was given, in 
December 1698, to John Clerk of Penicuik (1676-1755, 
and second baronet from 1722) just before his departure 
from the Florentine court of Cosimo ill (1642- 1723), 
Grand Duke of Tuscany (reigned from 1670). The chest 
was later described, by its new owner, as 'a Box of 
chyrnical medicines' .9•10•11 Figure 1 shows the top tray of 
the opened chest, Figure 2 shows the bottom tray of the 
chest, and Fig. 3 shows the ( covered) glass container and 
a ' dosage leaflet' for the deep red ointment under study. 
Analytical Methods and Results 
The analytical techniques used were: LVSEM (Low 
Vacuum Scanning Electron Microscopy) and two GC-
MS (Gas Chromatography-Mass Spectrometry) 
analyses. The first technique gives a quantitative 
summary of the elements present ( down to and including 
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Figure 1. The opened medicine chest, showing the top 
drawer 
Figure 2. The bottom drawer of the medicine chest 
an atomic number of 6, i.e. carbon) and the second 
technique gives data on the organic compounds present. 12 
The analytical results for our sample ( designated 
'Pl7') are given below: first the LVSEM results in 
decreasing order of elemental weight percent and then a 
summary of the GC-MS results. 
LVSEM:C,O 
GC-MS: Two analyses were done; Total Ion 
Chromatogram (TIC) GC-MS and Fatty Acid Methyl 
Esterification (FAME) GC-MS. Their results are 
summarised below, with additional data given in the 
Endnote.13 
TIC GC-MS: Ten of the seventeen compounds identified 
were saturated carboxylic (fatty) acids (FAs, to a total of 
almost 90%), ranging from C8:0 to C20:0 and with 
Cl6:0 (common name palmitic acid, P) and Cl8:0 
(common name stearic acid; S) having the largest 
amounts present (56.6% and 20.1 % respectively). The 
remainder consisted of two aldehydes (C8 and C9, to a 
total of 1.9%), three dicarboxylic acids (C8:0, C9:0 and 
ClO:O, to a total of 4.1%) and two carboxylic acid 
isomers (ofC18:l and Cl8:2, to a total of3.6%). 
FAME GC-MS: Ten of the thirty compounds identified 
were saturated straight-chain carboxylic acids 
(C8/9/10/12/14/16/17/18/20/22:0, to a total of 69.3%) 
and where the palmitic and stearic acids have the highest 
amounts present (35.2% and 25.4% respectively). 
Additionally there were: seven dicarboxylic acids (C6:0 
to Cl2:0, to a total of about 23.5% and where the C9:0 
acid had the largest amount, at 9.8%); three Cl8:2 
isomers (to a total of 1.2%); seven oxo-/dimethoxy-
/hydroxy-/dihydroxy- derivatives of various saturated 
fatty acids (to a total of 2.4%); two branched saturated 
fatty acids (of Cl6:0 and Cl7:0, at 2.4% and 0.2% 
respectively) and a trans-isomer ofC18:l (estimated to 
be at about 1 %). . 
Interpretation of the GC-MS data will be done in the 
next section. 
Discussion and Conclusions 
Not very many old medicinal residues have been 
analysed by modem analytical chemical techniques, and 
the number is even smaller for such residues where its 
use is known (from a convenient label/leaflet) or thought 
to be known ( from provenance data or previous literature 
publications). 
Two examples of chemical analyses of very old 
samples ( about two millennia in age), where the exact 
medicinal ( or possibly cosmetic) uses are uncertain, have 
been recently published. One, on a single sample from an 
Etruscan tomb (in Chiusi, Tuscany, Italy) dated to 
150/125 to 100 BC, found evidence for a a vegetable oil 
(possibly moringa) mixed with two plant resins (mastic 
and pine ). 14 Toe other article gives details of the analysis 
of seven residues in (four) bronze containers, which are 
part of a set of Roman-period surgical instruments and 
accessories held in the British Museum. Ingredients 
identified included: beeswax (some of which is probably 
'Punic wax'), fat/oil, conifer resin, gum-derived sugars, 
elemental carbon and lead and zinc compounds. 15 In 
both these studies one of the analytical techniques used 
was GC-MS; which is usually ideal for the identification 
of a whole range of organic molecules, and at least some 
of their degradation products. 
By the time we reach the late 19th century the 
previously commonly used beeswax had been largely 
replaced by the cheaper, and more readily available, 
petroleum products of paraffin wax/Vaseline. Also, the 
'active ingredients' held in the basis were often mostly, or 
even entirely, inorganic. These can be identified by the 
analytil:al techniques of LVSEM and XRPD. Very 
recently we published an article on the composition of 
two such skin medicines, one for eczema and the other 
for 'dry skin' problems, where both contained lead and 
mercury compounds as the active ingredients in a 
petroleum basis.16 
Residues of remedies, for bums/bruises/wound healing 
and various skin conditions, from Europe of the 16th and 
17th centuries, have occasionally been found and 
chemically studied. These results can be directly 
compared to sample 'Pl 7' in terms of usage, time/place 
of manufacture, chemical composition and degree of 
degradation. 
One such example is an ointment residue found in the 
excavated remains of a Belgian castle and dated to 
between the second half of the 16th century and the early 
17th century. Its organic fraction was studied mainly by 
the GC-MS analytical technique. Interpretation of all the 
collected data indicated that the original ointment had 
consisted of a lead plaster, beeswax and a small amount 
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of gypsum (CaS04.2H20). A lead plaster is an impure 
lead soap, made by mixing a lead compound (such as 
litharge, PbO) with a vegetable oil (such as olive or 
almond oil) or with an animal fat. Such a remedy was 
known to have been used in this time period/place as an 
external dressing for bruises, sores or ulcers. 17 
Other examples, together with remedies reproduced 
from relevant old recipes, were recently studied by 
Pyrolysis--GC/MS. The four old ointment residues were 
obtained from labelled containers in the Aboca Museum 
(Sanseprolcro, Arezzo, Italy), and had been dated from 
the 16th and 17th centuries. The results showed the 
presence of, variously, in both old and new samples: 
beeswax, gums/resins, animal (pig) fat and vegetable 
oils. As expected some degradation of the old samples 
had occurred; and for the artificially aged (via 
ozonolysis) reproduced remedies a small degree of 
degradation was sometimes observed. Also, some of the 
known ingredients of the reproduced samples could not 
be identified ( e.g. ground red rose petals extracts/rose 
water, turnip juice and various herbs). This gives some 
indication of how difficult it can be to correctly identify 
all the components of a medicinal remedy, especially 
when some of them have been changed over time by air 
(oxidation), water (hydrolysis) and general environm-
ental contamination. IS 
My GC-MS data shows no evidence for the presence 
of wax ( e.g. beeswax) or plant resin ( e.g. pine resin) in 
our sample. It does show evidence for the presence of 
fat/oil. The main components of fats and oils are 
triacylyglycerides (TAGs); where each molecule is an 
ester of glycerol and three carboxylic (fatty) acids. These 
acids are of variable ( carbon) chain length and can be 
saturated or unsaturated. In old fats and oils these TAG 
molecules are often at least partly hydrolysed to their 
component fatty acids (FAs). Such acids predominate in 
both of the GC-MS data sets (see above and associated 
Endnote); thus suggesting the presence in our original 
sample of one or more fat/oil. These FAs (and the TAGs 
prior to hydrolysis) can be subject to oxidation, and even 
degraded by any bacteria/microbes that may be present. 
My sample was probably in a warm ( estimated to be, 
usually, between 10 and 200 C) and dry closed environ-
ment, in a glass container, covered with tied-on vegetable 
parchment paper, in the medicine chest (see Fig. 1) for 
just over 300 years. Thus a degree of oxidation of the 
sample is to be expected from atmospheric oxygen, and 
any hydrolysis would be from the water which was part 
of the original sample and also perhaps from the local 
environment. Figure 2 shows the bottom tray of the chest 
and of the ten containers present it can be seen that five 
show a significant darkening/degradation of their 
parchment coverings. The sample (see Fig. 3) also has a 
partially darkened covering, showing that there has been 
some interaction between the inside of the container and 
the local environment via the semi-porous vegetable 
parchment paper. 19 
Oxidation products were found, the FAME GC-MS 
data giving a range of short carbon-chain dicarboxylic 
acids (C6:0 to Cl2:0, with a maximum at C9:0), and 
various oxo-/dimethoxy-/hydroxy-/dihydroxy derivat-
ives of several saturated FAs. Dicarboxylic acids are 
formed by the oxidative cleavage of a carbon-carbon 
double bond of a longer carbon-chain FA. The 
predominance of the C9:0 dicarboxylic acid (and the 
presence of some mono-carboxylic C9:0 acid) suggests a 
'parent' of oleic acid (Cl8:l). Thus we have fifteen 
oxidation products, to a total presence of 28.2%. 
Unsaturated FAs degrade faster that the saturated ones, 
and in our sample we have very little remaining 
unsaturated fatty acids (three isomers of C18:2 and the 
trans-9-isomer ofC18:1 , to a total ofabout2.2%).13 
My pattern of FAs (from the FAME GC-MS data) 
suggests the presence of an animal fat, i.e. palmitic acid 
(P, C16:0) and stearic acid (S, C18:0) being present in 
significant and similar amounts (i.e. a few tens of percent 
each) and smaller amounts (i.e. under 3% each) of (8) 
mostly even-numbered saturated FAs. The presence of 
C9:0 has already been explained, and the small amounts 
of the two other odd-numbered FAs (Cl 7:0, straight and 
branched chain) are also suggestive of the presence of an 
animal fat in our original sample. IJ,20,21,22 
A more detailed study of my FAME GC-MS data and 
the calculation of various FA ratios should help to 
distinguish ruminant from non-ruminant fat, and also 
perhaps determine if a mixture is present, such as two 
different fats or fat and oil. The ratios, and their various 
discriminatory values, used below are ones using only 
saturated acids. This was initially done because it was 
thought a) these acids degraded at a much slower rate 
than the unsaturated acids and b) that the acids used for a 
particular ratio degraded at about the same rate, and so 
their ratio value would not greatly change over time. 
However, it was later found, mostly from studies. on 
artificially aged fats and oils, that saturated FAs can 
sometimes degrade/oxidise at different rates, where these 
rates depend critically on the sample's composition and 
local environment. The 'degree ofrobustness ' of various 
ratios have been widely discussed, and so their results 
should be used cautiously, as 'indications' of what was 
present originally. If at all possible they should be used in 
conjunction with additional information.22 Our (ratio) 
data below will therefore be interpreted in terms of the 
strength of the 'indications' of what were the original 
components in my sample, rather than giving definitive 
proof of their existence. 
Perhaps the most well known FA ratio is Palmitic 
acid/Stearic acid (P /S, C 16:0/C 18 :0). A 'cut-off' value of 
1.3 is often quoted/used (but sometimes 1.0), where P/S 
> 1.3 suggests a non-ruminant fat and < 1.3 a ruminant 
fat. My ratio is 35.2/25.4, giving 1.4 and so indicating a 
non-ruminant fat (taken here to be pig fat - suet or 
lard).20.21 
The next FA ratio is in fact a combination of two ratios: 
Stearic acid/Palmitic acid (SIP) and Cl 7:0 br. (branched-
chain)/Cl8:0. If SIP > 0.5 then (terrestrial) animal fat is 
suggested (if < 0.5 then plant oil or marine animal fat is 
suggested), and if Cl 7:0 br./C18:0 is < 0.02 then non-
10 Pharm Hist (Lond) 2016; 46 (1): 
http://dx.doi.org/10.24355/dbbs.084-201801041429
· ruminant fat is suggested (and > 0.02 suggests ruminant 
fat). Our values are: SIP= 0.7 and Cl7:0 br./Cl8:0 = 
0.008; which again inciicates a non-ruminant fat. 23 
Toe last ratio is one combining six FAs. If the ratio 
(Cl5:0 + Cl7:0)/(Cl2:0 + Cl4:0 + Cl6:0 + Cl8:0) is 
>0.04 then ruminant fat is suggested and if < 0.04 then 
non-ruminant fat. Our value is 0.02, and so indicates once 
more a non-ruminant fat. 24 
Thus, overall, there are several indications for the 
presence of pig fat in the original sample. While one such 
indication should be treated with caution, it is felt that 
having three such indications adds strength to the 
interpretation. 
Additionally, there are small amounts(< 3% each) of 
two unsaturated FAs present (three isomers ofC18:2 and 
the trans-9-Cl8:l isomer) and Cl6:0 (branched-chain). 
Toe source of these compounds is unclear, but they could 
indicate the additional presence of a plant oil and/or a 
ruminant (possibly dairy) fat. 17.zo,24 
As already mentioned the results from FA ratios should 
ideally be combined with additional (analytical) 
information. Unfortunately it proved impossible to have 
other MS techniques applied to our sample (such as: gas 
chromatography-combustion-isotopic ratios mass spectr-
ometry, GC-C-IRMS). However, the FA ratios results 
can also be interpreted contextually and be integrated 
with information from relevant old recipes found in 
pharmacopoeias published before the making of our 
original sample (i.e. late 17th century). Two such relevant 
old recipes were found: 
'Unguentum Pro Jgne' ( ointment for fire, i.e. a burns 
ointment); two similar recipes from the ' Secreti 
Nobilissimi del Nuovo Autore detto il Greco' (Noble 
secrets by the new author known as 'The Greek') of 
1641. The (red) colorant was always filtered beetroot 
juice; and both contained pork (suet) fat, common oil 
(olive oil) and new wax (beeswax). Additionally, one 
Figure 3. The covered glass container of the ointment, 
and its 'dosage leaflet' from John Clerk of Penicuik's 
medicine chest. 
recipe contained some 'Silver Litargiriurn' (litharge, 
PbO, which is also red in colour).25 
'Unguentum Rosatum' (rose ointment; used as an 
astringent and restorative for various skin diseases); one 
recipe from the Pharmacopoeia Augustana (by Adolfo 
Occo, 1524-1606) of 1597. Its deep red colour comes 
from rose water and (ground and macerated) fresh red 
rose petals; with pork (suet) fat and (sweet) almond oil, 
the latter being the smaller amount present.25 
Given that my sample does not contain beeswax or 
litharge, then the recipe most comparable to mine is that 
for 'Unguenturn Rosaturn' above. Its usage is close to my 
sample (see below) and the main component is (very 
probably) pig fat. Almond oil could be present in my 
sample. However, some of the components of the red 
colorant (rose water/extract ofred rose petals) are often 
subject to a degree of degradation (usually oxidation) 
over time, and so are not usually found. 1s,2s 
A translation of the 'dosage leaflet' for the burns 
ointment, found underneath its glass container (Fig. 3) in 
the bottom drawer of the medicine chest, is given below 
( and where the words in square brackets have been added 
byus): 
Ointment fur burns 
Ofthe Fonderia [Foundry] ofS.AS. 
ointment wotb 'wonderfully fur all bums 
·chever way they could occur, and if [the 
· , , em] is applied immediately; it will heal 
·ckly with .no need ·for other remedies., and \vilil 
wninate pall and the bw:rung sensation preventmg 
,eruption of Wisteru . . Apply ~ to the 
part,. covering wnh lettuce leai.res, 
epeating the application ro.-o or three times a day. 
[Th.is oinhnent] wotk:s fur the clJaps in a 
'Olll.all's nipples, fur ,cracks of the bands, scrapes 
fissures, for bw:st lips., and fO£ frostbite of the 
. as well as for ery:t.ipelas [ a severe contagious 
· . infection] lesions appfymg to the offended 
art, ~nd oovering \Vith s:ome lettuce leaves, and can 
l!J500. mice a day, that is e.seaing and morning. 
· is a special secret in the &oyal Fouruky of 
SAS .. and not in anyone else's hands., as those who 
:ray to bav,e the same secrets. 
[SAS. is Sua Altezza Serenis.sima (His Most Serene Highness)] 
The fonderia of the Grand Dukes of Tuscany was their 
workshop/laboratory for research into and the production 
of various materials relating to the Arts and to Alchemy. 
In addition to the initial furnaces for smelting and forging 
metals, there were added over time facilities for studying 
and making: medicines, porcelain, cabinets, confec-
tionery, clocks and other mechanical devices, and for the 
cutting of precious/semi-precious stones. Its location 
varied over time; it being found, in chronological (if 
sometimes overlapping) order, in the Palazzo Vecchio 
(located at the NE end of the Uffizi gallery), the Casino 
di San Marco and in what is now the Uffizi gallery itself. 
However, from the time of the reign ofCosimo II (1590-
1621 ; reigned from 1610) its prestige and facilities 
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decreased and under his successor (F erdinando II, 1610-
70) its budget, and hence output, was increasingly 
reduced. Under Cosirno ID (reigned 1670-1723) the 
fonderia was moved to the Palazzo Pitti where it 
apparently functioned only as a phannacy.26.27 The very 
existence of this chest and its contents confirms the above 
and also suggests an associated Workshop for making the 
medicine chests and their distinctive 'dosage leaflets'. 
Various fats and oils have been used in skin remedies 
for millennia (see previous Introduction and associated 
references1-8). The fats and oils were used to conserve the 
outer layer of the skin and to protect any broken areas 
whilst it healed; and some of their components' 
molecules, along with those of any added ingredient(s), 
could transfer into the skin. This transfer would be 
enhanced if the skin was broken. Jn Europe of the last 
few centuries, pig fat, almond oil and rose preparations 
have often been (individually or together) so used ---
sometimes mixed with other materials, sometimes 
not. 6,1s,2s 
Historically almond oil has been used to treat skin 
conditions (such as psoriasis and eczema), and as an 
effective skin emollient. It is now thought to have anti-
inflarnmatory, immunity-boosting and anti-
hepatotoxicity effects, and is being considered for study 
for use post-operatively to reduce scarring.28 
Dried rose petals were used in the past for skin care, 
and rose preparations were variously medicinally used, 
for example as: astringent, anti-bacterial agent, anti-
septic and for their general cooling effects on damaged 
skin. Also, more recently, rose extracts/isolates have been 
tested for anti-HIV activity.6.29 
It is unclear if the lettuce leaves, mentioned in the 
above 'dosage leaflet', were intended to have a 
pharmaceutical effect when used or if they were just for 
the convenience of covering the sticky ointment on the 
skin. Very recent work has shown that green lettuc_e 
leaves do contain bioactive compounds that have antI-
inflarnmatory and anti-oxidant potential. 30 
Determining the original chemical composition of an 
'ooze' that is over 300 years old was never going to be 
straightforward. As expected, there was a degree of 
degradation. Fifteen of the thirty molecules found (to a 
total presence of 28.2%) from the FAME GC-MS 
analysis were recognisable oxidation prod11:cts of a f~t or 
oil. This is consistent with the sample bemg kept m a 
warm and dry environment for about three centuries. 
From my results its original composition probably was: 
an animal fat, very likely pig fat, as the main compone?t; 
a smaller amount of a plant oil and/or a ruminant milk 
fat; and a red colorant. However, if my analytical data is 
integrated with old relevant recipes th~n w_e sho~d ~e 
able to see a little further. The relevant histoncal recipe m 
this case, from a pharmacopoeia probably consulted ( or 
perhaps copied from) in the fonderia of The G~d Duke 
of Florence in the mid.-to-late 17th century, 1s that of 
'Unguentum Rosatum' (Rose Ointment). This gives a 
better understanding of what my sample's original 
composition probably was, that is: pig suet fat as the 
major component, sweet almond oil as the Ininor 
component and the deep red colour from rose 
water/extracts. Thus history (historical recipes) augments 
chemistry (residue analysis). 
Provided the skin area was clean then using the 
ointment as a covering for a burn or bruise would have 
been a good way to protect it from infection. Applying it 
for a severe skin aflliction is more problematic, but using 
it would at least have contained the infection. The use of 
lettuce leaves to cover the ointment would at least have 
kept its 'stickiness' in check, and may even have aided 
recovery. 
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The Indian Lancet 
Harkishan Singh 
Professor Emeritus, Panjab University, 
Chandigarh, India 
When on superannuation as a pedagogue in 1988 I 
engaged in studies on the history of pharmaceutical and 
related developments in India, I was professionally 
mature. I noted more than two dozen topics and 
subtopics on which I would need to collect source 
material. On my visits to different archive centres within 
the country and abroad I looked for information on all the 
subjects in view. Some other areas not originally thought 
of but appearing of interest while on the job also became 
topics of equal attention. Studies on the history of certain 
obsolete journals was one such theme. 
The oldest such periodical which came to my notice 
was the Madras Quarterly Journal of Medical Science at 
the Connemara Public Library at Madras (now Chennai). 
The journal started publishing in 1860, later changing to 
Madras Monthly Medical Journal in 1870 and ceasing to 
exist in 1873.1 The Indian Lancet, tracing its first 
appearance as The Medical Reporter in 1892, is the 
subject of this paper. . 
At the College of Physicians in Philadelphia I was able 
to locate some issues of the Indian Journal of Pharmacy 
which had started publication in January 1894 from 
Calcutta.2 The Indian and Eastern Druggist, starting 
publication in 1920, not from India but from London, 
appeared from Calcutta for about four years as Indian 
and Eastern Chemist from 1937 onwards.3 
The Medical Reporter 
In the beginning of my studies on medico-pharmaceutical 
history of India, I came across a reference to a Medical 
Reporter citation, a journal which was unknown to me. 
My initial efforts to know about the periodical were 
fruitless and it seemed that mine was a wild-goose chase. 
However, later in the early 1990s when I was working at 
the National Library in Calcutta, a microfilm of the first 
five volumes of the journal became available. I had page 
prints made of the selected parts, from the Bhai Gurdas 
Library of the Guru Nanak Dev University at Arnritsar. 
The collection gave me some useful source material. 
The Medical Reporter started publication in January 
1892 from 35 Wellington Street, Calcutta, with Lawrence 
Fernandez, MD, as the Editor and Proprietor.4 It was felt 
that 'For some reason or other, we in India are almost 
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totally devoid of medical literature and the spirit of 
independent medical journalism exists so feebly, that it 
has scarcely ever, eve in a single instance, been able to 
plant itself on a finn basis, in the shape of a well supported 
and popular organ' .5 The medical literature available 
mostly came from Europe. The existence of the Indian 
Medical Gazette from Calcutta was 'mainly attributed to 
the official recognition and support it received'. The other 
journal of the time was the Indian Medical Record also 
from Calcutta; it had been favourably received and was an 
independent organ. It was stated, 'We as advocates of 
independent medical literature, wish our contemporary 
many more years of independent successful existence; 
and enter upon the field of rivalry for benefiting medical 
science'.5 
The Medical Reporter was well received and the editor 
recorded that 'We are glad to say our first two issues have 
been received with greater favour, and encouragement 
tl1an we expected' .6 The objective of the periodical 
remained ' the furtherance of Medical Sciences, 
especially as it refers to the tropics '. 
On 1 January 1894 The Medical Reporter 'entered 
upon a new feature in its career: that from a monthly it 
has developed into a fortnightly at no extra cost to the 
subscribers' . 7 This was entirely due to the generous and 
encouraging support the journal had received. From now 
on fuey published two volumes a year for the periods 
January-June and July-December. From volume 2 to 
volume 6 the publication office was the Medical-
Publishing Press, 5 Royd Street, Calcutta. 
The Medical Reporter remained truly a Record of 
Medicine, Surgery, Public Health and of General 
Medical Intelligence, but off and on there appeared in it 
material which I found of interest for research as a 
historian of pharmaceutical and related developments in 
Jndia of the colonial period. I noted down many 
references to the source material of interest and some of 
these I have already used for my writings. 
For biographic coverage, supplementary information 
became available on active workers engaged in study and 
propagation of the Indigenous Drugs of India. These 
included Rai Bahadur, Kanny Lall Dey,8 William 
Dymock,9 Edward John Waring, 10 and Sir William 
O'Shoughnessy Brooke. 11 References to some other 
subjects were also collected. 
The Indian Lancet 
By now I had come to know of the existence of The 
Indian Lancet and how the journal had been a 
continuation of The Medical Reporter. When I started 
working at the National Medical Library at New Delhi I 
could lay hands on volumes 6 (July-December 1895) to 
16 (July-December 1900), eleven in the series. The 
popularity which The Medical Reporter had gained, 
prompted the editor to change the name to The Indian 
Lancet from 1 November 1895, adopting the Lancet part 
after fue world famous general medical journal The 
Lancet (London). 12 
My search for more information on the journal had 
been an ongoing process all through. It was Geoffrey 
TH£ MEDICA,L REP~RTER, 
A RECORD OF MEDlCINE, SURGERY, PUBLIC HEALTH, 
AND 
m' GENERAL . MEDICAL INTELLIGENCE. 
EOITED BY 
LAWRENCE J':ERNANDEZ M.D., 
189~. 
VOLUME 1. 
G"lt!!IU TT1'1-, 
THE " MElille,tlo•f"Ulllt1StiLfl0 • P~E5S, 38, WEL.ltlfHilTON STREET, 
Figure 1. Title page ofVolume 1 of The Medical Reporter. 
Davenport of the Royal College of Physicians, London, 13 
who provided me wifu relevant pages of the World List 
of Scientific Periodicals, 14 from which I learnt that the 
Indian Lancet was published from Calcutta during the 
period 1895-1908. Later, it was through correspondence 
with Ian Milne15 and Estela Dukan 16 of the Royal College 
of Physicians of Edinburgh (RCPE) that much source 
material on TheMedical Reporter and Indian Lancet was 
obtained. Dukan also brought to my notice a paper by 
Sanku Bilas Roy, 17 who had located volumes 12, 13 and 
15 of The Indian Lancet in India. 
The Library of the Royal College of Physicians of 
Edinburgh has in their possession the entire set of 
volumes of the Medical Reporter and up to volume 23 
(1904) of The Indian Lancet. All that I needed for my 
studies was made available through correspondence. 
The l"ldian Lancet continued to be edited by Dr 
Lawrence Fernandez and the press was now renamed as 
The "Indian Lancet" Press located at 5 Royd Street, later 
changing to 6 Royd Street from publication of volume 
11; from volume 21 the location was 3 Wellesley Street. 
During 1897 the Indian Lancet office was damaged by 
an earthquake and for some weeks the work had to be 
carried out in a propped-up half-demolished building.18 
The journal remained a fortnightly publication, changing 
to a weekly from volume 17 (1901). 
The Indian Lancet broadly remained the Journal of 
Medicine, Surgery, Public Health, and of General 
Medical Intelligence. The journal published some 
original rese~ch articles, current medical literature, 
special correspondence and 'a mirror of practices.' Each 
volume was divided into several chapters according to 
the month. At the end of each chapter, there were 
Government medical notifications which consisted of 
topics such as Gazette of India, Retirements, 
Appointments and Promotions in Medical Departments. 
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THE INDIAN LANCET. 
A WBKll:LY 
JOURNAL OF MEDICINE, SURGERY, PUBLIC HEALTH, 
AND 
OF GENERAL MEDICAL INTELLIGENCE. 
EDITED BY 
LA.WIUiN CE PERNA.NDHZ, lf.D. 
VOLUME XXIII. 
U..NUil.Y TO JUNE 1U04,. 
CALCUTTA : 
THE "INDtAN LANCET" PRESS, 3, W ELLESLEY STREET, 
Figure 2. Title page ofVolume 23 of the Indian Lancet. 
From The Indian Lancet volumes I noted down scores 
of references on topics such as biographies, cinchona 
plantations, botanical gardens, antiquity of Indian 
medicine and indigenous drugs, medical education, sales 
of poisons, drug adulteration, civil dispensaries, 
compounders, etc. I continue to use the appropriate 
source material for my writings. 
By courtesy of the Royal College of Physicians of 
Edinburgh Library mostly I was able to make studies 
using material drawn from The Indian Lancet up to 
volume 23 (1904). Unsuccessful efforts were made to 
reach the remaining volumes of the periodical. Recently 
I learnt about likely availability of volumes from 1904 to 
1908 at the Wellcome Library, London, 19 but my enquiry 
drew a blank from that end, their possession of the 
volumes was only up to 1903.20 
The only biographical information I have found on Dr 
Fernandez has come through Estela Dukan.21 Fernandez 
passed the Double Qualified Examination of the Royal 
College of Surgeons ofEdinburgh and Royal College of 
Physicians of Edinburgh in 1885.21 .22 He also held MD 
from Brussels.22 The entry in the Register of Licentiates 
of the Royal College of Physicians of Edinburgh shows 
his birth in India at 'Poodopat.' 
It is interesting to note that Dr Fernandez disappeared 
from the Medical Register and Medical Directory around 
1908, so he possibly died around that time.21 This is 
understandable since Dr Lawrence Fernandez was not 
only the editor throughout but also the proprietor of the 
publication. 
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The Rise and Fall of the Liverpool 
Apothecaries Company 1836 to 1904 
Dr Stuart A Anderson 
London School of Hygiene and Tropical Medicine 
London 
Tue first half of the nineteenth century, between the 
passage of the Apothecaries Act in 1815 and the 
foundation of the Phannaceutical Society of Great 
Britain in 1841, was a fonnative and influential period in 
the history of British phannacy. The Apothecaries Act 
had facilitated the transformation of the apothecaries into 
general medical practitioners who began to re-define the 
boundaries of their new roles. At the same time these 
shifting boundaries created opportunities for the growing 
numbers of chemists and druggists to establish 
themselves in retail and wholesale businesses. Many of 
these had little experience of business and no 
pharmaceutical qualifications of any kind. 1 
Around the country the different groups of health 
practitioner responded to the new situation in different 
ways and at different speeds. Liverpool during this 
period was a prosperous and bustling city. It had 
dominated the slave trade right up to the abolition of the 
latter in 1807, and it remained a major port for the arrival 
of sailing ships laden with cotton for the Lancashire 
mills, sugar for refining locally, along with tobacco and 
other commodities. In such a thriving city medical 
practitioners of all types were generally able to make a 
good living. 
With little in the way of regulation it is hardly 
surprising that a proportion of the drugs supplied were of 
inferior quality, had been adulterated or had deteriorated 
with age. It was perhaps also inevitable that the new 
breed of apothecaries practising as general medical 
practitioners around the country recognised the 
opportunity to make additional profit by taking control of 
the supply of medicines for themselves and their 
colleagues by setting up their own manufacturing 
companies. And not surprisingly, such apothecaries soon 
came into conflict not only with the local chemists and 
druggists, but also with the local physicians and 
surgeons. In these battles the apothecaries were able to 
claim the moral high ground by emphasising that what 
motivated them was purely concern with the quality of 
the medicines available and not. the profit to be made. 
This paper describes the rise and fall of the short-lived 
Liverpool Apothecaries Company, from its origins in 
1836, through to its demise in 1860.2 The story takes in 
some early controversies in 1839 and 1840, an 
intervention from Jacob Bell in 1849, and the eventual 
takeover of the company. In fact the company never 
enjoyed the success its founders expected, and in 1860 it 
became the Liverpool branch of the General 
Apothecaries Company based in London. The branch 
itself went into liquidation in 1874, but the name of the 
Liverpool Apothecaries Company was resurrected as a 
Liverpool chemists business until the company was 
finally dissolved in 1904. 
The Liverpool Apothecaries Company was not the 
first local Apothecaries Company to be established: that 
honour fell to Glasgow. The Glasgow Apothecaries 
Company was formed by a group of twelve medical 
practitioners in 1805, in Wilson Court in Argyle Street. 
They were concerned that most of their prescriptions 
were actually being dispensed at shops owned by other 
doctors, and they decided that the solution was to open 
their own business. Before long other doctors and 
chemists in the area used the company, and a wholesale 
department was opened. There are records showing that 
in January 1819 the Glasgow Apothecaries Company 
paid Howard's, who much later went on to manufacture 
aspirin, the sum of £213 for drugs. 
Other Apothecaries Companies were formed, 
sometimes in the same city as existing ones. The New 
Apothecaries Company was established in 1824 in 
similar circumstances to the original Glasgow one by 
seven well-known physicians, including a Professor 
Rainey. The premises were in Glassford Street in 
Glasgow, and the first manager was William Grieg. He 
had served his apprenticeship with the Glasgow 
Apothecaries Company. The New Apothecaries 
Company was subsequently owned and managed by four 
generations of the Grieg family, before eventually being 
sold to Evans Medical in Liverpool. 
The Liverpool Apothecaries Company, founded in 
1836, was the next to be founded, but it was not the last. 
Although the supposed justification for its origin was 
concern with the adulter!ltion of medicines, other factors 
included not only financial greed by the apothecaries but 
also local protests about the dominance of the London 
Society of Apothecaries. 
The problem of drug adulteration in the 
early nineteenth century 
Concern about the adulteration of medicines continued 
for years after the Apothecaries Act of 1815. In 1825 a Dr 
Paris published a book entitled Pharmacologia,3 in 
which he stated that 'the ignorant preparation and 
fraudulent adulteration of medicines deserve to be ranked 
amongst the most powerful causes which have operated 
in affecting the reputation of many medicinal 
substances'. He referred specifically to Peruvian bark 
which, he claimed, had fallen into total discredit in 1779, 
from its 'inability to cure the ague, and it was afterwards 
discovered to have been adulterated with bark of an 
inferior species' . 
In 1833, three years before foundation of the Liverpool 
Apothecaries Company, a group of practitioners in 
Liverpool had protested, in a letter to The Lancet, against 
the Worshipful Society of Apothecaries of London being 
given control of medicine, and they had appealed for a 
repeal of the Apothecaries Act of 1815. They commented 
'these men and their company are utterly unknown in the 
history of medicine and bear the same rank in medical 
sciences as does the Fishmongers Company in natural 
science or the Stationers Company in general literature' .4 
In 1834 a Select Committee of the House of Commons 
was appointed to inquire into and report on medical 
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education. In the course of the committee's enquiries 
abundant evidence was given 'of the truth of Dr Paris's 
allegations' about adulteration. The committee noted, 
however, that despite the evidence, no legislation had 
been passed for the protection of the public. There was 
no adequate existing means, they concluded, of ensuring 
the supply of pure medicinal substances and their 'due 
and faithful compounding according to the formularies 
or prescriptions of physicians' . 
Origins of the Liverpool Apothecaries 
Company 
It was against this background that the Liverpool 
Apothecaries Company was founded, on 30 May 1836, 
with a capital of £100,000. It was an ambitious scheme. 
Its first task was to acquire land to build the substantial 
premises it would require. It purchased a plot at 4 
Colquitt Street, at the comer with Wood Street in what is 
now central Liverpool. There it built a warehouse, 
chemical and pharmaceutical laboratories, and a retail 
shop; these were erected at a total cost of £30,000. The 
premises were known as the Liverpool Apothecaries 
Hall. 
. r: · 
were used for the creation of corporations or government 
offices, or for the granting of city status or a coat of arms. 
However, as a result of the opposition of the President of 
the Board of Trade, the Bill was withdrawn. 
The formal deed of constitution, dated 183 7, gives the 
names of the directors, staff and trustees of the Company, 
together with details of its aims and organisation.6 The 
first chairman was Andrew Gillon, a surgeon; four of the 
seventeen members of the board were physicians, five 
were surgeons, one was a broker and another was a 
merchant. Of the three trustees, one was a physician and 
another was a surgeon. Only one, Joseph Churton, was a 
Licentiate of the London Apothecaries. The manager was 
Robert Clay, the secretary Herny Forshaw and the 
traveller Mr M Chatterton. 
In January 1838, when the Company had been in 
existence for 18 months, and (according to the 
memorialists) had 'acquired a reputation that ensured its 
usefulness', a deputation from the board of directors 
consulted the new President of the Board of Trade, the Rt 
Hon H Labouchere, who was then in Liverpool. 
Labouchere strongly recommended that they made 
immediate application 
for a grant of Letters 
Patent, giving them a 
monopoly. This they 
did, but the Letters 
were not granted . 
The Company 
appears to have faced 
considerable oppos-
ition to its 
establishment, from 
several sources both 
local and national. Its 
supporters objected to 
the complaints about it 
being a 'monopoly' 
Figure 1. The Hall and Buildings of the Liverpool Apothecaries Company, comer of Colquitt that were raised 
Street and Wood Street, Liverpool. against it from several 
In accordance with practice at the time Memorials ( or 
testimonials) were presented to the Queen by the 
chairman and directors of the company.5 This was the 
process by which the directors made application to 
Parliament for a Bill to give them the facility of suing and 
being sued in the name of their chairman, confirming 
their legal status. However, the Bill was opposed by the 
then President of the Board of Trade, who advised its 
withdrawal, recommending that the directors wait 'until 
the public should have experience of the working of the 
establishment' . 
The directors could then apply for Letters Patent, in 
which the legislators would have the power of binding 
them to certain conditions. Letters Patent were a type of 
legal instrument in the form of a published written order 
issued by a monarch, generally granting an office, right, 
monopoly, title, or status to a person or corporation; they 
sources. The managing 
committee of the 
Druggists Association, headed by a wholesale dealer in 
Liverpool and backed by travellers employed by the 
larger wholesale houses of London, succeeded in raising 
petitions from various places against the granting of 
Letters Patent. And not surprisingly, the Solicitor of the 
Worshipful Society of Apothecaries of London opposed 
the name adopted by the Company. 
Despite this vociferous opposition, the Memorials ( or 
testimonials) contained many letters of support for the 
Company. These came from practitioners in various parts 
of Great Britain, including James Simpson in Edinburgh 
and Robert Keate, sergeant-surgeon to the Queen. Not 
surprisingly two of the Company's own staff, Dr RH 
Brett, the chemist and analyst, and Robert Clay, the 
manager, also wrote letters of support. But despite these 
efforts no Letters Patent were ever granted. 
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The Peruvian bark controversy 1839 
· The new Company was soon involved in the first of 
several controversies1_ On February 5 1839, it rather 
rashly offered a public challenge, that the bark in the 
Company's possession was genuine Loxa Peruvian bark, 
as proved incontrovertibly by its external characteristics 
and by the analysis of the Company's chemist. The 
challenge was accepted by someone using the 
pseudonym 'Oh' who issued a broadsheet addressed to 
'the chairman of the Company assuming the title of the 
Liverpool Apothecaries Company, when it is a well-
known fact that butchers, bakers, shoemakers, tailors or 
chimney-sweeps may, by holding shares in this 
speculation, with equal right and propriety, designate it 
after their particular or joint vocations' . 
'Oh's' challenge was not that the bark was adulterated, 
but rather that any claim on the basis of a test by the 
Company's own chemist was invalid. 'Oh' claimed that 
the bark purchased by the Company had to be shown to 
be false by the 'real and legislatively authorised 
Apothecaries Company of London'. Despite the 
publicity given to the challenge at the time the outcome 
of the dispute is not known. 
The Lancet campaign 1839 
Shortly afterwards, letters attacking the Liverpool 
Apothecaries Hall started appearing in The Lancet. The 
first was signed under the pen name 'Machaon' (in Greek 
mythology Machaon was the surgeon son of Asclepius 
and Epione).7 It stated that in Liverpool 'a number of the 
physicians, surgeons and apothecaries .. . have united in 
a joint-stock Company, with a host of unqualified 
individuals, and have, in imitation of the worthies of 
Rhubarb Hall, appropriated to themselves the specious 
title of 'The Apothecaries Company'. 7 
The letter went on to criticise the Company's pretence 
that its main concern was for the dispensing of genuine 
drugs, and securing the public against adulteration; and it 
alleged that the Company had become wholesale and 
retail vendors of all kinds of advertised nostrums. 
A second letter, signed by 'a general practitioner,' 8 also 
called the assumption of the title a fraud, 'for that 
Company is composed of trading speculators of various 
grades and callings, the purchase and possession of 
shares being all that is required as the qualification of a 
director, whether the subject be a tailor, tinker, butcher or 
whatever else.' This letter also -referred to the spurious 
bark controversy, and repeated the charge of selling 
quack and secret remedies. 8 It also appears that 
correspondence on the bark question had been previously 
published in the Liverpool Mercury. 
The controversy rumbled on, but eventually the 
Company hit back at its critics. In a letter dated 21 May 
1840, Clay, the manager, stated that be had been engaged 
in the business of chemist and druggist in Liverpool for 
the last 34 years, since 1806, and declared that 'the 
scientific and professional measures daily practised in the 
establishment of the Liverpool Apothecaries Company, 
with the view of securing pure drugs for medical 
purposes, are most necessary in order to protect the 
Figure 2. Front elevation of the Liverpool Apothecaries 
Company. 
medical profession and the public from the adulteration 
practised in the manufacture, preparation and 
compounding of drugs' . 
David Waldie and the fires of 1845-46 
The early years of the Company were further hindered by 
two fires in fairly close succession. The first, on 20 
March 1845, involved the mill, but fortunately the main 
building containing the laboratories was separated from 
it by a street. But on 17 July 1846, the warehouse and 
laboratories were destroyed by a further fire. The damage 
was clearly extensive; none of the apparatus which had 
been used by David Waldie for his experiments on the 
manufacture of chloroform survived.9 
David Waldie was a surgeon and apothecary, but his 
main interest was chemistry. In 1839 he replaced Dr Brett 
as chemist and analyst to the Liverpool Apothecaries 
Company, giving up his medical practice in the process. 
He found that the quality of chloroform in use from 1836 
was variable, and he set about preparing a purer form. He 
met Dr James Young Simpson in Edinburgh in 1847 and 
promised to send him some of the pure liquid on his 
return to Liverpool. But the fire meant that he could not 
do so, and it seems Duncan Flockhart and Co. in 
Edinburgh obtained Waldie's method from Simpson, 
who then obtained supplies from them. 10 
Simpson acknowledged Waldie's contribution to the 
successful use of chloroform as an anaesthetic in a 
footnote to a paper he published on 15 November 1847,11 
but unfortunately omitted such reference in subsequent 
publications. · There has since been widespread 
recognition that Waldie did not receive the credit he 
deserved for the introduction of chloroform into 
anaesthesia. 12 
Waldie himself continued his work at the home of his 
friend John Abraham in Liverpool. However, in 1853 he 
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took up the post of chemist to the firm of Malcolm and 
Co. in Calcutta, India, although he continued to 
correspond withAbraham until the latter's death in 1881. 
It seems that Waldie also remained friendly with 
Simpson; he does not seem to have been greatly 
concerned about the claims for recognition of his part in 
the introduction of chloroform into anaesthesia. He later 
founded his own firm of analytical and manufacturing 
chemists near Calcutta, where he died in 1888. 13 
The Liverpool Chemists' Association 
and the intervention by Jacob Bell 1849 
One thing working in the favour of the new Liverpool 
Apothecaries Company was the lack of unity displa~ed 
by the local chemists and druggists. Before the founding 
of the Pharmaceutical Society of Great Britain in 1841 
the chemists and druggists of Liverpool had been a 
disparate and disorganised group.14 Prior to 1849 
attempts to form an association of chemists had been 
unsuccessful; in that year, however, a meeting ofbetween 
forty and fifty chemists in Liverpool resulted in the 
formation of the Liverpool Chemists' Association. 15 
This name was chosen in preference to the title 
Liverpool Branch of the Pharmaceutical Society in order 
to encourage those engaged in the profession, but not 
members of the Pharmaceutical Society, to join.16 Some 
years later, in 1922, it was decided to form a branch of the 
Pharmaceutical Society within the Association consisting 
of pharmacists who were already members of the 
Figure 3. Side elevation of the Liverpool Apothecaries 
Company showing Wood Street facade. 
Pharmaceutical Society. After this time the name of the education and qualification. His outburst was just one 
association was expanded to indicate its dual purpose; it more episode in his long campaign to regulate the 
became the Liverpool Chemists' Association and qualifications of pharmaceutical chemists. On 12 June 
Liverpool and District Branch of the Pharmaceutical 1851 he introduced a bill in the House of Commons to 
Society of Great Britain.17 this effect, along with other proposals relating to the 
In 1849 Jacob Bell, a leading figure in the Society in practice of pharmacy. The bill eventually became the 
London at the time, was invited to address a meeting of Pharmacy Act of 1852. 
the newly formed Liverpool Chemists' Association. But Not surprisingly the Liverpool Apothecaries Company 
he succeeded in misjudging the relationship between the resented the imputation of being 'insignificant and on its 
apothecaries and the chemists and druggists locally, and last legs', and their then manager, a Dr Joseph Anderson 
in so doing he managed to start another controversy for MD, wrote a long letter to the Pharmaceutical Journal, 
the Liverpool Company. The theme of his address was pointing out Bell's inconsistency in stating that the 
the connection between education and protection, and to charge of the unreliability of drugs was unfounded, but 
illustrate it he referred to the Apothecaries Hall of was at the same time impossible to repudiate. 19 
Liverpool as being a concern which was, he claimed, Bell who was also the editor of the Pharmaceutical 
probably ' insignificant and reported to be on its last legs' , Journ~l at the time, published the letter, but added three 
but which had nevertheless 'occasioned some degree of pages of justification for his views.20 Whilst apologising 
annoyance and injury to the chemists of the locality.' He for his incautious remark about the financial state of the 
commented that the pretext on which the Company was Company, he expanded on his theme about the need for 
founded had been the allegation that medical education, which would have rendered the foundation of 
practitioners could not depend on the accuracy of the Company unnecessary. For good measure he made 
chemists, or on the purity of their drugs, and that it was scathing references to the two fires that had occurred at the 
therefore necessary for the safety of the public for the Liverpool Apothecaries Hall, and other remarks which 
apothecaries to form their own Company. 18 would today be regarded as libellous. It is surprising that 
Bell acknowledged that this was something of a the controversy appears to have gone no further. 
sweeping statement, but it was not one that could easily Bell's response also revealed that the petitions of the 
be refuted. Unfortunately it could not be denied that Company for Letters Patent had been unsuccessful 
many persons were carrying on businesses as chemists because of the opposition of the Liverpool chemists. His 
and druggists who had had no education and whose attack and his later statement reveal an uncharacteristic 
drugs were bad and adulterated. Changing this situation lack of preparation and judgement, because there is 
necessitated legislation to create acceptable standards of considerable evidence of cordial relations between the 
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Liverpool Apothecaries Company and the Liverpool 
Chemists' Association. Robert Clay, the Company's 
manager, was president of the Liverpool Chemists' 
Association at the time of the controversy and in the 
following year; and John Abraham, who was also 
employed by the Liverpool Apothecaries Company, was 
president of the Association in 1856-57, and again in 
1870-71. 
Members of the two organisations frequently spoke at 
each other's meetings. Jn his presidential address in 1869 
Abraham said that 'Dr Richard Brett was one of our 
earliest lecturers, and Mr David Waldie (Dr Brett's 
successor as chemist to the Company) delivered the first 
lecture addressed to us '. 21 These lectures were held in the 
Liverpool Royal Institution, which was also in Colquitt 
Street. Bell's intervention does not seem to have done 
much for relations between the two, and it doubtless took 
some time for the damage caused by Bell to be repaired. 
The final years 
The failure to obtain Letters Patent and hence a 
monopoly of supply meant that the Liverpool 
Apothecaries Company always struggled to make much 
of a return for its investors, selling its products either 
locally or further afield. To make matters worse other 
competitors entered the market. Jn 1856 a General 
Apothecaries Company was founded in London, at a 
time when the Worshipful Society of Apothecaries at 
Blackfriars was itself a substantial manufacturer of 
medicines.22 Rather than continuing to compete with the 
Liverpool Company, the General Apothecaries Company 
approached it with a view to amalgamation. After 
protracted discussions this finally occurred in 1860. 
The Liverpool Apothecaries Company was formally 
dissolved and reconstituted as the Liverpool branch of 
the General Apothecaries Company. The first mention of 
the new Liverpool branch of the Company appears in a 
Minute Book on 18 February 1860, when the profit for 
the half-year was reported as £155 19s. 2d., an increase 
of £35 10s. 7d. on the previous half year. Amongst the 
shareholders listed for the new company was Joseph 
Anderson MD, previously manager of the Liverpool 
Company and now a director of the new one. The 
General Apothecaries Company also opened a branch in 
Birmingham for a short time. 
Creation of the new enlarged General Apothecaries 
Company entailed the dissolution of the old company 
and the creation of a new one. A Notice appeared in The 
London Gazette dated 2 Aprirl861, under the heading 
'General Apothecaries Company (Limited), No. 49, 
Bemers Street, London, and No. 4 Colquitt Street, 
Liverpool. Completely registered, 9th October 1856' . 
Liquidators had been appointed at an Extraordinary 
General Meeting held on 28th April 1860 to wind up the 
affairs of the old company. Notice was now given that 
another 'Extraordinary General Meeting of the 
shareholders will be held at No. 49 Bemers Street, 
London, on Saturday 4th May 1861, at one o'clock, pm, 
for the purpose of considering the Liquidators ' account, 
and if the Meeting is of the opinion that the affairs of the 
Company have been fairly wound up, to pass a resolution 
to that effect' . 23 
The Liverpool branch of the General Apothecaries 
Company survived for another fourteen years. A 
reference to the issue of the final liquidation account of 
the Liverpool branch of the Company appeared in March 
1874. It showed that the net result of the sale of the lease, 
fittings, furniture, stock and book debts was £1 ,271 14s. 
9d, and that the net loss in trading was £2,059 6s. 7 d. The 
Liverpool Apothecaries Company thus closed through 
no fault of its directors after a quarter of a century of 
business, although the name itself survived for another 
thirty years.24 
Revised Articles, Rules and Regulations for the 
General Apothecaries Company, which now operated 
only in London, were published on 18 April 1888.25 As 
the Company was no longer trading in Liverpool it could 
have no objection to allowing the name of The Liverpool 
Apothecaries Company to be. used by a retail chemists' 
business in Liverpool using the Colquitt Street premises. 
It seems likely that the name of the company was sold 
along with the lease to the premises and the furniture and 
fittings. The new business was later run as a partnership 
between three chemists and druggists, although only one 
of them gave their address as 4 Colquitt Street; this was 
W R Roberts, who had registered on 26 April 1882. Of 
his partners AM Hugill, who. gave his address as 50 Lord 
Street, Liverpool, had registered three years earlier, on 18 
June 1879, and J Overton, whose address was given as 
50A Lord Street, had registered five years before that, on 
15 May 1874. 
This business continued until 1904 when it was 
dissolved, and the name finally ceased to be used. A 
Notice appeared in The London Gazette o/31 May 1904, 
indicating that ' the Partnership heretofore subsisting 
between us the undersigned, Arthur Major Hugill, John 
Overton, and William Rowe Roberts, carrying on 
business as Chemists, at 4, Colquitt Street, Liverpool, in 
the county of Lancaster, under the style or firm of 'the 
Liverpool Apothecaries Company, ' was dissolved as and 
from the twenty-second day of May, 1904, by mutual 
consent. Dated the twenty-seventh day of May, 1904. ' 
The names of all three appear on the 1903 Register of 
Chemist and Druggists.26 
The General Apothecaries Company itself, based in 
London, went on to continue in business until 1959, 
when it too went into voluntary liquidation. The 
Liverpool Apothecaries Hall building remained in 
existence until 1941. Jn 1934 a reporter noted that it had 
' fallen on evil times' and was then used by the Burlington 
Rooms and Cafe. Later it was used as a warehouse by 
Morton's, a very high class furnishers in Bold Street. But 
in the May blitz of 1941 the old Liverpool Apothecaries 
Hall was completely destroyed by a land mine, and the 
site was later occupied by one of the factories of 
Wetheralls, who made camping gear and overalls. 
Authors address: Stuart.Anderson@lshtrn.ac.uk 
A shorter version of this paper was presented at the 
BSHP Annual Conference 2014, Liverpool . 
Phann Hist (Lond) 2016; 46 (1): 21 
http://dx.doi.org/10.24355/dbbs.084-201801041429
Endnotes and References 
1. Holloway, SWF. Royal Pharmaceutical Society 
of Great Britain 1841-1991: A Political and Social 
History. London: Pharmaceutical Press, 1991 : 31-82. 
2. Richmond, L, Stevenson, J and Turton, A (eds) . 
Pharmaceutical Industry: A Guide to Historical 
Records. Aldershot, Rants: Ashgate, 2003: 10. 
3. Paris, JA. Pharmacologia:Corrected and exten-
ded, in accordance with the London Pharmacopoeia 
of 1824, and with the generally advanced state of 
chemical science. New York: Wood, Lockwood and 
Collins, 1825. 
4. Letter. Lancet 1883; 1: 120. 
5, Copy of Memorials and petitions presented to the 
Queen in Council. Mayer Papers, volume 3: 76. 
Liverpool: Liverpool Record Office. 
6. Deed of constitution of The Liverpool Apoth-
ecaries Company, May 30, 1836. Liverpool: Liver-
pool Record Office. 
7. 'Machaon'. Lancet 1838-9; 1: 600. 
8. A General Practitioner. Lancet 1838-9; 2: 80. 
9. Whittet, TD. The Liverpool Apothecaries Company: 
3 Final Years. Chemist and Druggist 1963 (July 10): 
40-42. A scrap book containing primary source material 
about the Liverpool Apothecaries Company was 
assembled by Dr Douglas Whittet, a former master of the 
Worshipful Society of Apothecaries of London, for use in 
the writing of his papers on this subject. On his death the 
book passed to Dr Juanita Bumby, and on her death it 
was bequeathed to the British Society for the History of 
Pharmacy. It has subsequently been donated to the 
Liverpool Record Office, Central Library, William 
Brown Street, Liverpool, L3 8EW, where it can be freely 
accessed. 
10. Waldie, D. Lancet 1847; 2: 687. 
11. Bell, J. Pharmaceutical Journal 1847-86:???? 
357. 
12. O 'Leary, AJ. Who was the person who 
discovered chloroform for anaesthesia? Was it 
Simpson or Waldie? British Journal of Anaesthesia, 
1934-5; 12: 41. 
13. Dundee, JW. David Waldie; Facts and 
Fiction. Anaesthesia 1953; 8: 218; Singh, H. David 
Waldie (1813-1889). Pharmaceutical Historian 
2014; 44.2: 45-48. 
14. Nevins, JB. Pharmacy in Liverpool. Chemist and 
Druggist 1953; 49: 133. 
15. A report of the first meeting of the Association 
appears in the Liverpool Mercury, 8 June 1849. 
16. Report (1850). Meeting of Pharmaceutical 
Chemists at Liverpool. Pharmaceutical Journal 
1849-50; 9: 40-46. 
17. Hunter AE. A History of Liverpool Pharmacy. 
Pharmaceutical Journal 1962; 135: 44-45. 
18. Whittet, TD. The Liverpool Apothecaries 
Company: 1. Origin and Early Days. Chemist and 
Druggist 1962 (Sept 8); 178: 278-9. 
19. Anderson, J (letter). The Liverpool Apothecaries 
Company, Pharmaceutical Journal 1849-50; 9 (3): 
105-106. 
20. Editorial Comment. Pharmaceutical Journal 
1849-50; 9 (3): 106-109. 
· 21. Abraham, J. (1870). Presidential Address to the 
Liverpool Chemists' Association, October 14 1869. 
Pharmaceutical Journal 1869-70; 11 (2nd series): 
347-351 (348). 
22. Hunting, P. A History of the Society of 
Apothecaries. London: Society of Apothecaries, 
1998: 153-187. 
23. London Gazette, 2 April 1861, 1434. Available 
at https://www.thegazette.co.uk/London/issue/22498/ 
page/1423. Accessed 7 December 2014. 
24. Whittet, TD. The Liverpool Apothecaries 
Company: 2. Waldie and his association with 
chloroform. Chemist and Druggist 1963 (March 2); 
179: 233. 
25. Articles, Rules and Regulations of the General 
Apothecaries Company. (18 April 1888). Liverpool: 
Liverpool Record Office. 
26. The London Gazette, 31 May 1904, 3509. 
Available at https://www.thegazette.co.uk/London/ 
issue/27681/page/3512. Accessed 7 December 2014. 
Julia Sheppard gave a talk on 'The Forgotten partner: 
Silas M Burroughs at the 8 February evening meeting at 
East Smithfield. 
ISSN: 0079-1393 Indexed in Medline as Pharm. Hist. (Lond.) 
© British Society for the History of Pharmacy 2016 
Typeset and Produced by Ralph Allen Press Ltd, Bath BAI 3EN 
22 Pharm Hist (Lond) 2016; 46 (1) : 
http://dx.doi.org/10.24355/dbbs.084-201801041429
